Neuroprotective effects of lithium in cultured cells and animal models of diseases

Authors

  • De-Maw Chuang,

    1. Section on Molecular Neurobiology, Mood and Anxiety Disorder Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA,
    Search for more papers by this author
  • Ren-Wu Chen,

    1. Section on Molecular Neurobiology, Mood and Anxiety Disorder Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA,
    Search for more papers by this author
  • Elzbieta Chalecka-Franaszek,

    1. Section on Molecular Neurobiology, Mood and Anxiety Disorder Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA,
    2. Department of Psychiatry, Uniformed Services University of Health Sciences, Bethesda, MD, USA
    Search for more papers by this author
  • Ming Ren,

    1. Section on Molecular Neurobiology, Mood and Anxiety Disorder Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA,
    Search for more papers by this author
  • Ryota Hashimoto,

    1. Section on Molecular Neurobiology, Mood and Anxiety Disorder Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA,
    Search for more papers by this author
  • Vladimir Senatorov,

    1. Section on Molecular Neurobiology, Mood and Anxiety Disorder Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA,
    Search for more papers by this author
  • Hirohiko Kanai,

    1. Section on Molecular Neurobiology, Mood and Anxiety Disorder Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA,
    Search for more papers by this author
  • Christopher Hough,

    1. Department of Psychiatry, Uniformed Services University of Health Sciences, Bethesda, MD, USA
    Search for more papers by this author
  • Toyoko Hiroi,

    1. Section on Molecular Neurobiology, Mood and Anxiety Disorder Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA,
    Search for more papers by this author
  • Peter Leeds

    1. Section on Molecular Neurobiology, Mood and Anxiety Disorder Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA,
    Search for more papers by this author

De-Maw Chuang PhD Section on Molecular Neurobiology, Mood and Anxiety Disorder Program, National Institute of Mental Health, 10 Center Dr MSC 1363, Bethesda, MD 20892–1363, USA. Fax: 301-480-9290; e-mail: chuang@helix.nih.gov

Abstract

Lithium, the major drug used to treat manic depressive illness, robustly protects cultured rat brain neurons from glutamate excitotoxicity mediated by N-methyl-D-aspartate (NMDA) receptors. The lithium neuroprotection against glutamate excitotoxiciy is long-lasting, requires long-term pretreatment and occurs at therapeutic concentrations of this drug. The neuroprotective mechanisms involve inactivation of NMDA receptors, decreased expression of pro-apoptotic proteins, p53 and Bax, enhanced expression of the cytoprotective protein, Bcl-2, and activation of the cell survival kinase, Akt. In addition, lithium pretreatment suppresses glutamate-induced loss of the activities of Akt, cyclic AMP-response element binding protein (CREB), c-Jun – N-terminal kinase (JNK) and p38 kinase. Lithium also reduces brain damage in animal models of neurodegenerative diseases in which excitotoxicity has been implicated. In the rat model of stroke using middle cerebral artery occlusion, lithium markedly reduces neurologic deficits and decreases brain infarct volume even when administered after the onset of ischemia. In a rat Huntington's disease model, lithium significantly reduces brain lesions resulting from intrastriatal infusion of quinolinic acid, an excitotoxin. Our results suggest that lithium might have utility in the treatment of neurodegenerative disorders in addition to its common use for the treatment of bipolar depressive patients.

Ancillary